Chloroquine in Combination With Carboplatin/Gemcitabine in Advanced Solid Tumors
The purpose of this research study is to test the safety of chloroquine in combination with carboplatin and gemcitabine and see what effects (good and bad) it has on advanced solid tumors.

Also, the research study will be increasing the dose of chloroquine to find the highest dose of chloroquine that can be given in combination with carboplatin and gemcitabine without causing severe side effects.
Malignant Neoplasm|Solid Tumors
DRUG: Chloroquine|DRUG: Carboplatin|DRUG: Gemcitabine
Maximum tolerated dose of chloroquine when combined with Carboplatin/Gemcitabine, Up to 12 months
Time to Disease Progression, Up to 24 months|Time of Overall Survival, Up to 24 months
The purpose of this research study is to test the safety of chloroquine in combination with carboplatin and gemcitabine and see what effects (good and bad) it has on advanced solid tumors.

Also, the research study will be increasing the dose of chloroquine to find the highest dose of chloroquine that can be given in combination with carboplatin and gemcitabine without causing severe side effects.